|
1ALD
ACTIVITY AND SPECIFICITY OF HUMAN ALDOLASES
Deposited 1991-05-05
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–363(363 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
2ALD
HUMAN MUSCLE ALDOLASE
Deposited 1998-10-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–363(363 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.5
|
Resolution 2.10 Å
R-free 0.258
|
|
4ALD
HUMAN MUSCLE FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE COMPLEXED WITH FRUCTOSE 1,6-BISPHOSPHATE
Deposited 1998-07-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–363(363 aa)
|
Not recorded
|
2FP 1,6-FRUCTOSE DIPHOSPHATE (LINEAR FORM) × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.5
|
Resolution 2.80 Å
R-free 0.304
|
|
5KY6
Human muscle fructose-1,6-bisphosphate aldolase
Deposited 2016-07-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–364(363 aa)
Chain B
2–364(363 aa)
Chain C
2–364(363 aa)
Chain D
2–364(363 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;292 K;1.6M ammonium citrate tribasic
|
Resolution 1.94 Å
R-free 0.223
|
|
6XMH
Human aldolase A wild type
Deposited 2020-06-30
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–364(364 aa)
Chain B
1–364(364 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 8
GOL GLYCEROL × 14
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.75;277 K;10% (w/v) PEG 8,000, 18% (v/v) glycerol, 0.04 M potassium phosphate, pH 5.75
|
Resolution 1.95 Å
R-free 0.286
|
|
6XMM
Human aldolase A I98S
Deposited 2020-06-30
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–364(364 aa)
Chain B
1–364(364 aa)
|
Mutation:I98S
Mutation:I98S
|
PO4 PHOSPHATE ION × 8
GOL GLYCEROL × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;10% (w/v) PEG 8000, 15% (v/v) glycerol, 0.04 M potassium phosphate, pH 6.0
|
Resolution 2.11 Å
R-free 0.295
|
|
6XMO
Human aldolase A I98F
Deposited 2020-06-30
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–364(364 aa)
Chain B
1–364(364 aa)
|
Mutation:I98F
Mutation:I98F
|
PO4 PHOSPHATE ION × 8
GOL GLYCEROL × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.75;277 K;12% (w/v) PEG 8000, 15% (v/v) glycerol, 0.04 M potassium phosphate, pH 5.75
|
Resolution 2.60 Å
R-free 0.259
|